Janux Therapeutics, Inc. (NASDAQ:JANX) Financings

Janux Therapeutics, Inc.

Financings

RaiseDate
Public offering of common stock and pre-funded warrants
Closed: US$402.5M raised · US$63 a share · BofA Securities +8
Dealers: BofA Securities (co-lead), TD Cowen (co-lead), Stifel (co-lead), Cantor (co-lead), William Blair (co-lead), Wedbush PacGrow, LifeSci Capital, BTIG, Jones
Use of proceeds: Advance clinical development of its internal product pipeline and general corporate purposes
Dec 6, 2024

Read by 6ix AI from the company's releases